We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 23, 2020

Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage HR+ Breast Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer Patients
Clin. Cancer Res 2020 Oct 02;[EPub Ahead of Print], W Schroth, FA Büttner, S Kandabarau, R Hoppe, P Fritz, J Kumbrink, T Kirchner, HA Brauer, Y Ren, DA Henderson, SF Madden, G Sauer, T Fehm, D Wallwiener, PA Fasching, TE Mürdter, M Schwab, G Tamoxifen Ai Clinicians Group, H Brauch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading